Cargando…

Glycogen storage disease type IIIa in pregnant women: A guide to management

Glycogen storage disease type IIIa (GSD‐IIIa) is an autosomal recessive disorder that impairs glycogenolysis, producing ketotic hypoglycaemia, hepatomegaly, cardiac and skeletal myopathy. During pregnancy, increased metabolic demand requires careful management. There are few case reports about pregn...

Descripción completa

Detalles Bibliográficos
Autores principales: Beneru, Demi, Tchan, Michel C., Billmore, Kate, Nayyar, Roshini
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995835/
https://www.ncbi.nlm.nih.gov/pubmed/35433175
http://dx.doi.org/10.1002/jmd2.12282
_version_ 1784684368493543424
author Beneru, Demi
Tchan, Michel C.
Billmore, Kate
Nayyar, Roshini
author_facet Beneru, Demi
Tchan, Michel C.
Billmore, Kate
Nayyar, Roshini
author_sort Beneru, Demi
collection PubMed
description Glycogen storage disease type IIIa (GSD‐IIIa) is an autosomal recessive disorder that impairs glycogenolysis, producing ketotic hypoglycaemia, hepatomegaly, cardiac and skeletal myopathy. During pregnancy, increased metabolic demand requires careful management. There are few case reports about pregnancy in GSD‐IIIa, however none detail management during caesarean section. This case describes a 25‐year‐old women with GSD‐IIIa diagnosed at 5 months of age. She had modest metabolic control with complications including hepatomegaly, mild skeletal myopathy and poor enteral function requiring multiple operative interventions. She had a planned pregnancy managed by a multidisciplinary team, which included a metabolic geneticist, maternal–fetal medicine specialist and metabolic dietitian. Nocturnal cornstarch was provided to meet basal carbohydrate requirements and a high protein diet with regular carbohydrates was consumed throughout the day. The woman remained well during the antenatal period and had an induction of labour at 38 weeks gestation. She had an emergency caesarean section in early labour due to an abnormal cardiotocography (CTG). The intraoperative and postoperative period were uncomplicated. A live baby boy was born in good condition, weighing 2440 g with APGARs of 9 and 9 at 1 and 5 min. She was managed in labour with glucose 10% IV at 3.5 mg/kg/min, hourly blood sugar level (BSL) monitoring and early epidural anaesthetic. The aim of the first 24‐h post‐partum was prevention of hypoglycaemia, which required strict management with dextrose 10% IV at 3.5 mg/kg/min, oral carbohydrate supplementation and BSL monitoring. This case highlights the complexity of GSD‐IIIa as well as provides a proposed plan for management during pregnancy.
format Online
Article
Text
id pubmed-8995835
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-89958352022-04-15 Glycogen storage disease type IIIa in pregnant women: A guide to management Beneru, Demi Tchan, Michel C. Billmore, Kate Nayyar, Roshini JIMD Rep Case Reports Glycogen storage disease type IIIa (GSD‐IIIa) is an autosomal recessive disorder that impairs glycogenolysis, producing ketotic hypoglycaemia, hepatomegaly, cardiac and skeletal myopathy. During pregnancy, increased metabolic demand requires careful management. There are few case reports about pregnancy in GSD‐IIIa, however none detail management during caesarean section. This case describes a 25‐year‐old women with GSD‐IIIa diagnosed at 5 months of age. She had modest metabolic control with complications including hepatomegaly, mild skeletal myopathy and poor enteral function requiring multiple operative interventions. She had a planned pregnancy managed by a multidisciplinary team, which included a metabolic geneticist, maternal–fetal medicine specialist and metabolic dietitian. Nocturnal cornstarch was provided to meet basal carbohydrate requirements and a high protein diet with regular carbohydrates was consumed throughout the day. The woman remained well during the antenatal period and had an induction of labour at 38 weeks gestation. She had an emergency caesarean section in early labour due to an abnormal cardiotocography (CTG). The intraoperative and postoperative period were uncomplicated. A live baby boy was born in good condition, weighing 2440 g with APGARs of 9 and 9 at 1 and 5 min. She was managed in labour with glucose 10% IV at 3.5 mg/kg/min, hourly blood sugar level (BSL) monitoring and early epidural anaesthetic. The aim of the first 24‐h post‐partum was prevention of hypoglycaemia, which required strict management with dextrose 10% IV at 3.5 mg/kg/min, oral carbohydrate supplementation and BSL monitoring. This case highlights the complexity of GSD‐IIIa as well as provides a proposed plan for management during pregnancy. John Wiley & Sons, Inc. 2022-03-22 /pmc/articles/PMC8995835/ /pubmed/35433175 http://dx.doi.org/10.1002/jmd2.12282 Text en © 2022 The Authors. JIMD Reports published by John Wiley & Sons Ltd on behalf of SSIEM. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Beneru, Demi
Tchan, Michel C.
Billmore, Kate
Nayyar, Roshini
Glycogen storage disease type IIIa in pregnant women: A guide to management
title Glycogen storage disease type IIIa in pregnant women: A guide to management
title_full Glycogen storage disease type IIIa in pregnant women: A guide to management
title_fullStr Glycogen storage disease type IIIa in pregnant women: A guide to management
title_full_unstemmed Glycogen storage disease type IIIa in pregnant women: A guide to management
title_short Glycogen storage disease type IIIa in pregnant women: A guide to management
title_sort glycogen storage disease type iiia in pregnant women: a guide to management
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995835/
https://www.ncbi.nlm.nih.gov/pubmed/35433175
http://dx.doi.org/10.1002/jmd2.12282
work_keys_str_mv AT benerudemi glycogenstoragediseasetypeiiiainpregnantwomenaguidetomanagement
AT tchanmichelc glycogenstoragediseasetypeiiiainpregnantwomenaguidetomanagement
AT billmorekate glycogenstoragediseasetypeiiiainpregnantwomenaguidetomanagement
AT nayyarroshini glycogenstoragediseasetypeiiiainpregnantwomenaguidetomanagement